Among these, anti-melanoma differentiation antigen 5 (MDA5) antibodies have been associated with a definite subset of dermatomyositis patients showing prominent cutaneous and lung involvements with rapidly progressive interstitial lung disease (RP-ILD). The gene discussed is IFIH1; the disease is dermatomyositis.